← Leaderboards
Robert William Finberg
Dana-Farber Cancer Institute
$14,464,760
Attributed
$14,464,760
Total exposure
18
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.7M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$24,064,128 · 19
By mechanism
U19$9,599,368 · 1
P01$5,429,784 · 2
R01$4,920,357 · 3
U54$2,897,543 · 2
R21$752,609 · 2
T32$226,134 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- Emmett Vance Schmidt$8,396,491
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionVirus DiseasesCytokineVirusImmune ResponseImmunityLeadProductionProteinsPathogenesisLaboratory MouseResearch StudyCellsResponseResearch PersonnelMediatingInflammatoryIn VitroMortality Vital StatisticsTlr2 GeneProgramsPathogenAffectBase
Grant awards (47)
International Immunocompromised Host Society 21st International Symposium on Infections in the Immunocompromised Host$7,000
R13 · FY2020 · AI · contact PI
International Immunocompromised Host Society's 20th International Symposium on Infections in the Immunocompromised Host$5,000
R13 · FY2018 · AI · contact PI
International Immunocompromised Host Society's 19th International Symposium on Infections in the Immunocompromised Host$6,000
R13 · FY2017 · AI · contact PI
18th International Symposium on Infections in the Immunocompromised Host$8,000
R13 · FY2014 · AI · contact PI
Cellular Immunity to Category A-C Viruses in Humans$2,955,191
U19 · FY2013 · AI · contact PI
Innate Immunity Hemorrhagic fever viruses$389,215
U54 · FY2013 · AI · contact PI
Cellular Immunity to Category A-C Viruses in Humans$3,143,817
U19 · FY2012 · AI · contact PI
Innate Immunity Hemorrhagic fever viruses$441,561
U54 · FY2012 · AI · contact PI
17th International Symposium on Infections in the Immunocompromised Host$8,000
R13 · FY2012 · AI · contact PI
Cellular Immunity to Category A-C Viruses in Humans$3,209,684
U19 · FY2011 · AI · contact PI
Innate Immunity Hemorrhagic fever viruses$463,149
U54 · FY2011 · AI · contact PI
Toll2011 Meeting, Decoding Innate Immunity$12,000
R13 · FY2011 · AI · contact PI
Innate Immunity and Herpes Simplex Infection$1,828,170
P01 · FY2010 · AI · contact PI
Innate Immunity Hemorrhagic fever viruses$484,627
U54 · FY2010 · AI · contact PI
Cellular Immunity to Category A-C Viruses in Humans$290,676
U19 · FY2010 · AI · contact PI
16th Symposium on Infections in the Immunocompromised Host$4,300
R13 · FY2010 · AI · contact PI
Innate Immunity and Herpes Simplex Infection$1,856,406
P01 · FY2009 · AI · contact PI
Innate Immunity Hemorrhagic fever viruses$437,430
U54 · FY2009 · AI · contact PI
Innate Immunity and Herpes Simplex Pathogenesis$305,210
R01 · FY2009 · AI · contact PI
Virus Infections: Pathogenesis and Host Immune Responses$226,134
T32 · FY2009 · AI · contact PI
Innate Immunity and Herpes Simplex Pathogensis$20,671
R01 · FY2009 · AI · contact PI
Innate Immunity & Hemorrhagic Fever Viruses$681,561
U54 · FY2008 · AI · contact PI
Innate Immunity and LCMV$348,116
P01 · FY2008 · AI · contact PI
Innate Immunity and Herpes Simplex Pathogenesis$305,210
R01 · FY2008 · AI · contact PI
Innate Immunity and LCMV$344,852
P01 · FY2007 · AI · contact PI
Innate Immunity and Herpes Simplex Pathogenesis$311,122
R01 · FY2007 · AI · contact PI
Pathogenesis of myocarditis$197,234
R21 · FY2007 · AI · contact PI
Innate Immunity and LCMV$353,369
P01 · FY2006 · AI · contact PI
TLRs in Innate Immunity to Viral Infection$349,344
R01 · FY2006 · AI · contact PI
Innate Immunity and Herpes Simplex Pathogensis$320,211
R01 · FY2006 · AI · contact PI
Pathogenesis of myocarditis$243,375
R21 · FY2006 · AI · contact PI
Innate Immunity and Herpes Simplex Pathogenesis$358,500
R01 · FY2005 · AI
TLRs in Innate Immunity to Viral Infection$357,750
R01 · FY2005 · AI
Innate Immunity and LCMV$342,268
P01 · FY2005 · AI
TLRs in Innate Immunity to Viral Infection$357,750
R01 · FY2004 · AI
Innate Immunity and LCMV$356,603
P01 · FY2004 · AI
CD14 Signaling and Activation of Innate Immune Response$390,229
R01 · FY2003 · GM
TLRs in Innate Immunity to Viral Infection$357,750
R01 · FY2003 · AI
CD14 Signaling and Activation of Innate Immune Response$380,933
R01 · FY2002 · GM
TLRs in Innate Immunity to Viral Infection$356,626
R01 · FY2002 · AI
CAR PROTEIN AND AUTO IMMUNITY$156,000
R21 · FY2002 · AI
CORE--CELL BIOLOGY FACILITY$0
P30 · FY2002 · AI
CD14 Signaling and Activation of Innate Immune Response$371,907
R01 · FY2001 · GM
CAR PROTEIN AND AUTO IMMUNITY$156,000
R21 · FY2001 · AI
CORE--CELL BIOLOGY FACILITY$0
P30 · FY2001 · AI
CD14 Signaling and Activation of Innate Immune Response$377,144
R01 · FY2000 · GM
CORE--CELL BIOLOGY FACILITY$188,033
P30 · FY2000 · AI